A Modest Proposal

Tom Levenson has an interesting idea:

A Modest Proposal: A Science Initiative for the Obama Administration

But I'd like to lay down one relatively cheap marker that would, I think, have a significant impact on both the culture and the productivity of American scientific research to a degree disproportionate to the underlying amount of dollars. It's not a new idea, and hardly original to me -but seeing as it has been completely out of court for almost a decade, I think it bears repeating, even if it is old news to veterans of the business.

More on a Modest Proposal

In this post, I laid out a first marker for what the new administration could do for science, calling for an expansion of support for young scientists and engineers -- grad students, post docs and new principal investigators.

For the new PIs, I suggested an increase in the number and shift in the emphasis of what are now called Faculty Early Career Development Program grants, arguing that the availability of no-strings attached discretionary research funds for young scholars would have a disproportionate bang for the buck.

Read both posts (and comments) in their entirety. What do you think?

More like this

Yesterday I blogged a bit about how the rollback of NIH research funding may impact scientists at research universities. In light of those comments, here's another news item worth your attention. The Boston Globe reports that Yale University may be in some amount of trouble for accepting lots of…
By way of DrugMonkey, we come across NIH's new working group that "will examine the future of the biomedical research workforce in the United States." It's headed by Princeton's Shirley Tilghman, who in a recent interview, said: At the root of the problem is the fact that we are overproducing Ph.D…
Over at the DrugMonkey blog, PhysioProf noted that a push to increase NIH postdoctoral fellowship stipend levels by 6% may have the effect of reducing the number of postdoctoral positions available. To this, the postdoctoral masses responded with something along the lines of, "Hey, it's possible…
I was going to write something about the latest analysis of NIH funding in Science, but DrugMonkey did the work for me so go read his post. The bottom line is that NIH funding goes through boom-bust cycles that cause instability throughout the biomedical fields. In boom times the biomedical…